Edoardo Burini

Title: Edoardo Burini: Innovator in Pharmaceutical Chemistry

Introduction

Edoardo Burini is a notable inventor based in Guidonia Montecelio, Italy. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 5 patents. His work focuses on developing innovative compounds that have potential therapeutic applications.

Latest Patents

Edoardo Burini's latest patents include groundbreaking formulations. One of his notable inventions is a crystalline form of 1-(4-{[6-amino-5-(4-phenoxy-phenyl)-pyrimidin-4-ylamino]-methyl}-4-fluoro-piperidin-1-yl)-propenone, along with its salt forms and processes for obtaining them. This compound is recognized for its utility as a BTK inhibitor. Another significant patent involves a crystalline form of (S)-[2-chloro-4-fluoro-5-(7-morpholin-4-yl-quinazolin-4-yl)phenyl]-(6-methoxy-pyridazin-3-yl)-methanol, which can be prepared as a pharmaceutical composition.

Career Highlights

Edoardo Burini is currently employed at Merck Patent GmbH, where he continues to advance his research and development efforts. His work has been instrumental in creating new pharmaceutical solutions that address various medical needs.

Collaborations

Edoardo has collaborated with esteemed colleagues, including Marco Poma and Michael Lange. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Edoardo Burini's contributions to pharmaceutical chemistry exemplify the impact of innovative thinking in medicine. His patents reflect a commitment to advancing healthcare through scientific discovery.